Literature DB >> 26438688

FoxO4 promotes early inflammatory response upon myocardial infarction via endothelial Arg1.

Min Zhu1, Sean C Goetsch1, Zhaoning Wang1, Robert Luo1, Joseph A Hill1, Jay Schneider1, Sidney M Morris1, Zhi-Ping Liu2.   

Abstract

RATIONALE: Inflammation in post-myocardial infarction (MI) is necessary for myocyte repair and wound healing. Unfortunately, it is also a key component of subsequent heart failure pathology. Transcription factor forkhead box O4 (FoxO4) regulates a variety of biological processes, including inflammation. However, its role in MI remains unknown.
OBJECTIVE: To test the hypothesis that FoxO4 promotes early post-MI inflammation via endothelial arginase 1 (Arg1). METHODS AND
RESULTS: We induced MI in wild-type and FoxO4(-/-) mice. FoxO4(-/-) mice had a significantly higher post-MI survival, better cardiac function, and reduced infarct size. FoxO4(-/-) hearts had significantly fewer neutrophils, reduced expression of cytokines, and competitive nitric oxide synthase inhibitor Arg1. We generated conditional FoxO4 knockout mice with FoxO4 deleted in cardiac mycoytes or endothelial cells. FoxO4 endothelial cell-specific knockout mice showed significant post-MI improvement of cardiac function and reduction of neutrophil accumulation and cytokine expression, whereas FoxO4 cardiac mycoyte-specific knockout mice had no significant difference in cardiac function and post-MI inflammation from those of control littermates. FoxO4 binds the Foxo-binding site in the Arg1 promoter and activates Arg1 transcription. FoxO4 knockdown in human aortic endothelial cells upregulated nitric oxide on ischemia and suppressed monocyte adhesion that can be reversed by ectopic-expression of Arg1. Furthermore, chemical inhibition of Arg1 in wild-type mice had similar cardioprotection and reduced inflammation after MI as FoxO4 inactivation and administration of nitric oxide synthase inhibitor to FoxO4 KO mice reversed the beneficial effects of FoxO4 deletion on post-MI cardiac function.
CONCLUSIONS: FoxO4 activates Arg1 transcription in endothelial cells in response to MI, leading to downregulation of nitric oxide and upregulation of neutrophil infiltration to the infarct area.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  FoxO4 protein, mouse; arginase; endothelial cells; inflammation; myocardial infarction

Mesh:

Substances:

Year:  2015        PMID: 26438688      PMCID: PMC4710860          DOI: 10.1161/CIRCRESAHA.115.306919

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  43 in total

1.  Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin.

Authors:  Zhi-Ping Liu; Zhigao Wang; Hiromi Yanagisawa; Eric N Olson
Journal:  Dev Cell       Date:  2005-08       Impact factor: 12.270

2.  Deleterious effects of methylprednisolone in patients with myocardial infarction.

Authors:  R Roberts; V DeMello; B E Sobel
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

Review 3.  Recent advances in arginine metabolism: roles and regulation of the arginases.

Authors:  Sidney M Morris
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

4.  Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity.

Authors:  Jiangning Yang; Adrian T Gonon; Per-Ove Sjöquist; Jon O Lundberg; John Pernow
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

5.  Serum levels of arginase I are associated with left ventricular function after myocardial infarction.

Authors:  Seldag Bekpinar; Figen Gurdol; Yesim Unlucerci; Seval Develi; Akar Yilmaz
Journal:  Clin Biochem       Date:  2011-06-17       Impact factor: 3.281

6.  Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta.

Authors:  Michael J Gray; Mirjana Poljakovic; Diane Kepka-Lenhart; Sidney M Morris
Journal:  Gene       Date:  2005-06-20       Impact factor: 3.688

7.  Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury.

Authors:  M R Litt; R W Jeremy; H F Weisman; J A Winkelstein; L C Becker
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

8.  Arginase inhibition mediates cardioprotection during ischaemia-reperfusion.

Authors:  Christian Jung; Adrian T Gonon; Per-Ove Sjöquist; Jon O Lundberg; John Pernow
Journal:  Cardiovasc Res       Date:  2010-01-01       Impact factor: 10.787

9.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization.

Authors:  Jing Chen; Eric E Bardes; Bruce J Aronow; Anil G Jegga
Journal:  Nucleic Acids Res       Date:  2009-05-22       Impact factor: 16.971

10.  Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus.

Authors:  Oskar Kövamees; Alexey Shemyakin; John Pernow
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

View more
  32 in total

1.  Hyperglycemia-impaired aortic vasorelaxation mediated through arginase elevation: Role of stress kinase pathways.

Authors:  Surabhi Chandra; David J R Fulton; Ruth B Caldwell; R William Caldwell; Haroldo A Toque
Journal:  Eur J Pharmacol       Date:  2018-11-28       Impact factor: 4.432

2.  FoxO4 promotes myocardial ischemia-reperfusion injury: the role of oxidative stress-induced apoptosis.

Authors:  Lingling Yu; Weifang Zhang; Chahua Huang; Qian Liang; Huihui Bao; Zhijian Gong; Minxuan Xu; Zhenzhen Wang; Minhua Wen; Xiaoshu Cheng
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

3.  The Functional Pluralism of Fibroblasts in the Infarcted Myocardium.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2016-10-28       Impact factor: 17.367

Review 4.  The Arginase Pathway in Neonatal Brain Hypoxia-Ischemia.

Authors:  Jana Krystofova; Praneeti Pathipati; Jeffrey Russ; Ann Sheldon; Donna Ferriero
Journal:  Dev Neurosci       Date:  2019-04-17       Impact factor: 2.984

5.  Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity.

Authors:  Kebria Hezaveh; Rahul S Shinde; Andreas Klötgen; Marie Jo Halaby; Sara Lamorte; M Teresa Ciudad; Rene Quevedo; Luke Neufeld; Zhe Qi Liu; Robbie Jin; Barbara T Grünwald; Elisabeth G Foerster; Danica Chaharlangi; Mengdi Guo; Priya Makhijani; Xin Zhang; Trevor J Pugh; Devanand M Pinto; Ileana L Co; Alison P McGuigan; Gun Ho Jang; Rama Khokha; Pamela S Ohashi; Grainne M O'Kane; Steven Gallinger; William W Navarre; Heather Maughan; Dana J Philpott; David G Brooks; Tracy L McGaha
Journal:  Immunity       Date:  2022-02-08       Impact factor: 31.745

6.  Cell biological mechanisms in regulation of the post-infarction inflammatory response.

Authors:  Nikolaos G Frangogiannis
Journal:  Curr Opin Physiol       Date:  2017-12-13

Review 7.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.

Authors:  Sumanth D Prabhu; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

Review 8.  Arginase: A Multifaceted Enzyme Important in Health and Disease.

Authors:  R William Caldwell; Paulo C Rodriguez; Haroldo A Toque; S Priya Narayanan; Ruth B Caldwell
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

9.  Mechanistic basis of neonatal heart regeneration revealed by transcriptome and histone modification profiling.

Authors:  Zhaoning Wang; Miao Cui; Akansha M Shah; Wenduo Ye; Wei Tan; Yi-Li Min; Giovanni A Botten; John M Shelton; Ning Liu; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-26       Impact factor: 11.205

10.  Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1.

Authors:  Anil Bhatta; Lin Yao; Zhimin Xu; Haroldo A Toque; Jijun Chen; Reem T Atawia; Abdelrahman Y Fouda; Zsolt Bagi; Rudolf Lucas; Ruth B Caldwell; Robert W Caldwell
Journal:  Cardiovasc Res       Date:  2017-11-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.